DNA ploidy and cyclin D1 expression in basal cell carcinoma of the head and neck

American Journal of Clinical Pathology

Volumn 115, Issue 6, 2001, Pages 805-813

  Staibano, Stefania ^a   Lo Muzio, Lorenzo ^a   Pannone, Giuseppe ^a   Mezza, Ernesto ^a   Argenziano, Giuseppe ^a   Vetrani, Antonio ^a   Lucariello, Antonio ^a   Franco, Renato ^a   Errico, Maria E ^a   De Rosa, Gaetano ^a  

^a NONE

Author keywords

Basal cell carcinoma; Cyclin DI; DNA ploidy; Epiluminescence microscopy; Prognosis

Indexed keywords

CYCLIN D1; DNA;

ANEUPLOIDY; ARTICLE; BASAL CELL CARCINOMA; CELL POPULATION; CONTROLLED STUDY; DIPLOIDY; EPILUMINESCENCE MICROSCOPY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

CARCINOMA, BASAL CELL; CYCLIN D1; DNA, NEOPLASM; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LUMINESCENT MEASUREMENTS; MICROSCOPY; PLOIDIES; PROGNOSIS; SKIN NEOPLASMS; SKIN PIGMENTATION;

EID: 17744374769     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/GGE7-WL7J-VRWD-R4VG     Document Type: Article

References (52)

1. Robinson JK, Rademaker AW, Goolsby C, et al. DNA ploidy in nonmelanoma skin cancer. Cancer. 1996;77:284-291.
2. Dzubow LM. Metastatic basal cell carcinoma originating in the supra-parotid region. J Dermatol Surg Oncol. 1986; 12:1306-1308.
3. Jacobs GH, Rippey JJ, Altini M. Prediction of aggressive behavior in basal cell carcinoma. Cancer. 1982;49:533-537.
4. Miller SJ. Biology of basal cell carcinoma, part 1. J Am Acad Dermatol. 1991;24:1-13.
5. Wieman TJ, Shively EH, Woodcock TM. Responsiveness of metastatic basal-cell carcinoma to chemotherapy: a case report. Cancer. 1983;52:1583-1585.
6. Costanza ME, Dayal Y, Binder S, et al. Metastatic basal cell carcinoma: review, report of a case, and chemotherapy. Cancer. 1974;34:230-235.
7. de Rosa G, Vetrani A, Zeppa P, et al. Comparative morphometric analysis of aggressive and ordinary basal cell carcinoma of the skin. Cancer. 1990;65:544-549.
8. De Rosa G, Staibano S, Barra E, et al. Nucleolar organizer regions in aggressive and nonaggressive basal cell carcinoma of the skin. Cancer. 1992;69:123-126.
9. De Rosa G, Staibano S, Barra E, et al. p53 protein in aggressive and non-aggressive basal cell carcinoma. J Cutan Pathol. 1993;20:429-434.
10. De Rosa G, Barra E, Guarino M, et al. Fibronectin, laminin, type IV collagen distribution, and myofibroblastic stromal reaction in aggressive and nonaggressive basal cell carcinoma. Am J Dermatopathol. 1994;16:258-267.
11. Staibano S, Boscaino A, Salvatore G, et al. The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin. Hum Pathol. 1996;27:695-700.
12. Roenigk RK, Ratz JL, Bailin PL, et al. Trends in the presentation and treatment of basal cell carcinomas. J Dermatol Surg Oncol. 1986;12:860-865.
13. Farmer ER, Helwig EB. Metastatic basal cell carcinoma: a clinicopathologic study of seventeen cases. Cancer. 1980;46:748-757.
14. Mikhail GR, Nims LP, Kelly AP Jr, et al. Metastatic basal cell carcinoma: review, pathogenesis, and report of two cases. Arch Dermatol. 1977;113:1261-1269.
15. Blewitt RW. Why does basal cell carcinoma metastasize so rarely? Int J Dermatol. 1980;19:144-146.
16. Mertens F, Heim S, Mandahl N, et al. Cytogenetic analysis of 33 basal cell carcinomas. Cancer Res. 1991;51:954-957.
17. Nowell PC. Cytogenetics of tumor progression. Cancer. 1990;65:2172-2177.
18. Bartek J, Lukas J, Bartkova J. Perspective: defects in cell cycle control and cancer. J Pathol. 1999;187:95-99.
19. Strauss M, Lukas J, Bartek J. Unrestricted cell cycling and cancer. Nat Med. 1995;1:1245-1246.
20. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res. 1996;68:67-108.
21. Bosch F, Jares P, Campo E, et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood. 1994;84:2726-2732.
22. Ellis CN, Burnette JJ, Sedlak R, et al. Prognostic applications of DNA analysis in solid malignant lesions in humans. Surg Gynecol Obstet. 1991;173:329-342.
23. Hedley DW, Friedlander ML, Taylor IW. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry. 1985;6:327-333.
24. Carrillo R, Candia A, Rodriguez-Peralto JL, et al. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors. Hum Pathol. 1997;28:160-165.
25. Argenziano G, Fabbrocini G, Carli P, et al. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions: comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol. 1998;134:1563-1570.
26. Cohen SM, Ellwein LB. Cell proliferation in carcinogenesis. Science. 1990;249:1007-1011.
27. Pines J. Cyclins, CDKs and cancer. Semin Cancer Biol. 1995;6:63-72.
28. Bartkova J, Lukas J, Strauss M, et al. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene. 1995;10:775-778.
29. Adelaide J, Monges G, Derderian C, et al. Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. Br J Cancer. 1995;71:64-68.
30. Berenson JR, Yang J, Mickel RA. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene. 1989;4:1111-1116.
31. 1/S cyclins and cyclin-dependent kinases characterize squamous cell carcinomas of the head and neck. Int J Cancer. 1997;73:551-555.
32. Callender T, el-Naggar AK, Lee MS, et al. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer. 1994; 74:152-158.
33. Gimenez-Conti IB, Collet AM, Lanfranchi H, et al. p53, Rb, and cyclin D1 expression in human oral verrucous carcinomas. Cancer. 1996;78:17-23.
34. Xu J, Gimenez-Conti IB, Cunningham JE, et al. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer. 1998;83:204-212.
35. de Rosa I, Staibano S, Lo Muzio L, et al. Potentially malignant and malignant lesions of the lip: role of silver staining nucleolar organizer regions, proliferating cell nuclear antigen, p53, and c-myc in differentiation and prognosis. J Oral Pathol Med. 1999;28:252-258.
36. Welkoborsky HJ, Hinni M, Dienes HP, et al. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann Otol Rhinol Laryngol. 1995; 104:503-510.
37. Holm LE. Cellular DNA amounts of squamous cell carcinomas of the head and neck region in relation to prognosis. Laryngoscope. 1982;92:1064-1069.
38. Munck-Wikland E, Auer G, Kuylenstierna R, et al. Image cytometry DNA analysis of invasive squamous cell carcinoma of the esophagus. Anticancer Res. 1989;9:545-549.
39. Rube C, Valet G, Eder M. Cellular DNA content and metastasis pattern in colorectal carcinomas. Virchows Arch A Pathol Anat Histopathol. 1988;413:419-424.
40. Hemmer J, Kreidler J. Flow cytometric DNA ploidy analysis of squamous cell carcinoma of the oral cavity: comparison with clinical staging and histologic grading. Cancer. 1990;66:317-320.
41. Herzberg AJ, Garcia JA, Kerns BJ, et al. DNA ploidy of basal cell carcinoma determined by image cytometry of fresh smears. J Cutan Pathol. 1993;20:216-222.
42. Garcia JA, Cohen PR, Herzberg AJ, et al. Pleomorphic basal cell carcinoma. J Am Acad Dermatol. 1995;32:740-746.
43. Fortier-Beaulieu M, Laquerriere A, Thomine E, et al. DNA flow-cytometric analysis of basal cell carcinomas and its relevance to their morphological differentiation: a retrospective study. Dermatology. 1994;188:94-99.
44. Frentz G, Moller U, Larsen JK. DNA flow cytometry of human epidermal tumours: intra- and intertumour variability in ploidy and proliferative characteristics. Virchows Arch B Cell Pathol Incl Mol Pathol. 1985;48:175-183.
45. Buchner T, Hiddemann W, Wormann B, et al. Differential pattern of DNA-aneuploidy in human malignancies. Pathol Res Pract. 1985;179:310-317.
46. Brinck U, Korabiowska M, Knapik J, et al. Comparison of the DNA content in recurrent and nonrecurrent basaliomas of the face. Pol J Pathol. 1998;49:97-100.
47. del Vecchio MT, Lazzi S, Bruni A, et al. DNA ploidy pattern in papillary renal cell carcinoma: correlation with clinicopathological parameters and survival. Pathol Res Pract. 1998;194:325-333.
48. Kolles H, Niedermayer I, Schmitt C, et al. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Wien). 1995;137:174-181.
49. El-Naggar AK, Dinh M, Tucker SL, et al. Numerical chromosomal changes in DNA hypodiploid solid tumors: restricted loss and gain of certain chromosomes. Cytometry. 1999;37:107-112.
50. Flagiello D, Gerhault-Seureau M, Padoy E, et al. Near haploidy in breast cancer: a particular pathway of chromosome evolution. Cancer Genet Cytogenet. 1998;102:54-58.
51. Ferno M, Baldetorp B, Borg A, et al. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. Acta Oncol. 1992;31:157-165.
52. Tanner MM, Karhu RA, Nupponen NN, et al. Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene. Am J Pathol. 1998;153:191-199.